These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27926780)

  • 1. Newly translated proteins are substrates for ubiquitin, ISG15, and FAT10.
    Spinnenhirn V; Bitzer A; Aichem A; Groettrup M
    FEBS Lett; 2017 Jan; 591(1):186-195. PubMed ID: 27926780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for an involvement of the ubiquitin-like modifier ISG15 in MHC class I antigen presentation.
    Held T; Basler M; Knobeloch KP; Groettrup M
    Eur J Immunol; 2021 Jan; 51(1):138-150. PubMed ID: 32686110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradation.
    Aichem A; Anders S; Catone N; Rößler P; Stotz S; Berg A; Schwab R; Scheuermann S; Bialas J; Schütz-Stoffregen MC; Schmidtke G; Peter C; Groettrup M; Wiesner S
    Nat Commun; 2018 Aug; 9(1):3321. PubMed ID: 30127417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proteomic analysis of endogenous FAT10 substrates identifies p62/SQSTM1 as a substrate of FAT10ylation.
    Aichem A; Kalveram B; Spinnenhirn V; Kluge K; Catone N; Johansen T; Groettrup M
    J Cell Sci; 2012 Oct; 125(Pt 19):4576-85. PubMed ID: 22797925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of a novel ISG15-ubiquitin mixed chain and its role in regulating protein homeostasis.
    Fan JB; Arimoto K; Motamedchaboki K; Yan M; Wolf DA; Zhang DE
    Sci Rep; 2015 Jul; 5():12704. PubMed ID: 26226047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ubiquitin-like modifier FAT10 inhibits retinal PDE6 activity and mediates its proteasomal degradation.
    Boehm AN; Bialas J; Catone N; Sacristan-Reviriego A; van der Spuy J; Groettrup M; Aichem A
    J Biol Chem; 2020 Oct; 295(42):14402-14418. PubMed ID: 32817338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAT10ylation as a signal for proteasomal degradation.
    Schmidtke G; Aichem A; Groettrup M
    Biochim Biophys Acta; 2014 Jan; 1843(1):97-102. PubMed ID: 23333871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAT10, a ubiquitin-independent signal for proteasomal degradation.
    Hipp MS; Kalveram B; Raasi S; Groettrup M; Schmidtke G
    Mol Cell Biol; 2005 May; 25(9):3483-91. PubMed ID: 15831455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FAT10 : Activated by UBA6 and Functioning in Protein Degradation.
    Pelzer C; Groettrup M
    Subcell Biochem; 2010; 54():238-46. PubMed ID: 21222287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugation of the ubiquitin activating enzyme UBE1 with the ubiquitin-like modifier FAT10 targets it for proteasomal degradation.
    Bialas J; Groettrup M; Aichem A
    PLoS One; 2015; 10(3):e0120329. PubMed ID: 25768649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The UBA domains of NUB1L are required for binding but not for accelerated degradation of the ubiquitin-like modifier FAT10.
    Schmidtke G; Kalveram B; Weber E; Bochtler P; Lukasiak S; Hipp MS; Groettrup M
    J Biol Chem; 2006 Jul; 281(29):20045-54. PubMed ID: 16707496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1.
    Bialas J; Boehm AN; Catone N; Aichem A; Groettrup M
    J Biol Chem; 2019 Mar; 294(12):4315-4330. PubMed ID: 30718280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis.
    Aichem A; Pelzer C; Lukasiak S; Kalveram B; Sheppard PW; Rani N; Schmidtke G; Groettrup M
    Nat Commun; 2010 May; 1():13. PubMed ID: 20975683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ubiquitin-like modifier FAT10 interferes with SUMO activation.
    Aichem A; Sailer C; Ryu S; Catone N; Stankovic-Valentin N; Schmidtke G; Melchior F; Stengel F; Groettrup M
    Nat Commun; 2019 Oct; 10(1):4452. PubMed ID: 31575873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15.
    Durfee LA; Lyon N; Seo K; Huibregtse JM
    Mol Cell; 2010 Jun; 38(5):722-32. PubMed ID: 20542004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ubiquitin-like modifier FAT10 covalently modifies HUWE1 and strengthens the interaction of AMBRA1 and HUWE1.
    Mueller S; Bialas J; Ryu S; Catone N; Aichem A
    PLoS One; 2023; 18(8):e0290002. PubMed ID: 37578983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of BECN1 by ISG15 plays a crucial role in autophagy regulation by type I IFN/interferon.
    Xu D; Zhang T; Xiao J; Zhu K; Wei R; Wu Z; Meng H; Li Y; Yuan J
    Autophagy; 2015 Apr; 11(4):617-28. PubMed ID: 25906440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Link between the ubiquitin conjugation system and the ISG15 conjugation system: ISG15 conjugation to the UbcH6 ubiquitin E2 enzyme.
    Takeuchi T; Iwahara S; Saeki Y; Sasajima H; Yokosawa H
    J Biochem; 2005 Dec; 138(6):711-9. PubMed ID: 16428300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ISG15 conjugation system.
    Durfee LA; Huibregtse JM
    Methods Mol Biol; 2012; 832():141-9. PubMed ID: 22350882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Nedd8-associated polypeptides: a model for deciphering the pathway for ubiquitin-like modifications.
    Norman JA; Shiekhattar R
    Biochemistry; 2006 Mar; 45(9):3014-9. PubMed ID: 16503656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.